Episódios
-
When Medical Affairs was a support function, it was enough to count the actions we performed to aid the missions of our collaborators in Commercial and R&D. Now that Medical is a strategic partner alongside these other functions, we must measure and message our OWN mission. But how can we draw a line of causality or at least contribution from actions to impact? Here we speak with Diana Morgenstern, MD, Fellow of the American College of Physicians, member of the MAPS EvGen Domain Team, and Executive Strategist in the IQVIA US Medical Affairs Center of Excellence, and Javier Lopez-Molina, MBA, Senior Director of in the US Medical Affairs Center of Excellence, IQVIA about exactly this challenge. And we ask a very important question: now that we appreciate the need to demonstrate impact and technologies exist that allow us to measure impact...what's holding us back?
-
As Medical Affairs professionals, many of us have moved from first careers in academia or healthcare. What did your colleagues say when you told them you were transitioning to pharma? Did they say you were going to the "dark side"? In this episode, we speak with Robert Atkinson, President of the Information Technology and Innovation Foundation and author of the recently published book, Technology Fears and Scapegoats: 40 Myths About Privacy, Jobs, AI, and Today’s Innovation Economy. And we explore the origins of negative opinions of the pharmaceutical industry, and whether a for-profit model can support both innovation and the society's best interests.
-
Estão a faltar episódios?
-
Modern scientific storytelling is about more than data dissemination — it's about creating meaning for the audience, and as such (as any good bard on the stool of a Medieval tavern knows) it requires truly understanding the audience's motivations and needs. However, scientific storytelling goes further. Our goals are not fiction nor purely entertainment — it's helping HCPs and KOLs make patients lives better. Here we talk about this approach with Murali Gopal, Vice President and Head of Medical Affairs at Phathom Pharmaceuticals and Dave Gulezian, co-Founder and CEO at Alucio. And we ask what is the ONE thing a company must implement in their transformation from the 40-slide deck to modern scientific storytelling. Spoiler alert: They actually agree and it's something that doesn't require budget.
-
We know the expectations of our job and we likely know the purpose of our organization. But what is the purpose of your role? What is the golden thread that guides your work? Does it connect to your personal purpose, your organization's purpose or both? Here we speak with Jill Donahue, author of the recently published (free!) book, "A Dose of Inspiration: 100 Purpose Stories from Pharma Leaders" about the individual and organizational benefits of discovering your purpose as an employee in the Life Sciences industry — as well as previewing some of the purpose stories Jill uncovered while writing the book.
Links:A Dose of Inspiration: 100 Purpose Stories from Pharma Leaders
Article: Tired of Being Told You Went to the Dark Side?
-
Continuing Medical Education (CME) is transitioning from in-person, day-long seminars to bite-sized, virtual, learn-at-your-own pace courses. Here we talk with experts from Wiley and the world of consulting about new directions in CME — and how to address the continuing need for social learning and perceived authority even as we make information more consumable.
-
Many of us think about machine learning and AI as a way for an audience to get information: We ask ChatGPT a question and it provides the answer. Here we explore machine learning as a way to get information about an audience — both audience segments/personas and individuals within these groups. We also discuss the limitations and data privacy concerns that distinguish what we "could" know from what we "should" discover. And it turns out machine learning is not just a tool for mining he external environment, but also a way to make sense of a company's internal data to discover hidden experts and resources within the company.
-
In our last podcast episode of this series, we talked with Matt Lewis. We discussed generative AI, what it is and how it may change and evolve the medical communications environment. Today, we dive into a really important area that can significantly influence your GenAI results - Prompt Engineering and other areas.
-
In this podcast, we delve into the world of omnichannel strategies in Medical Affairs, where understanding your audience's educational needs and communication preferences is pivotal for delivering relevant and engaging data dissemination.
Join us as we explore how to develop effective communications by leveraging various sources of audience understanding, and how to translate information into actionable insights.
Discuss what the gold standard for insights could look like and highlight practical suggestions for how to yield robust insights while navigating common challenges often associated with using insights.
This podcast provides an overview into the multifaceted process of understanding your audience and explains the complexities and opportunities within the Medical Affairs space to ensure that your communications resonate with your audience, and ultimately, support their educational goals.
-
In Medical Affairs, our eyes are open to the vast possibilities of Artificial Intelligence — not only to make our current work more efficient, but to expand our capabilities in areas we never considered possible. Here, MAPS speaks with experts from Pfizer and Putnam Associates about the most exciting current uses of AI and also where we may be headed in the future. Join us for a wild ride through the possibilities of AI.
-
MAPS speaks with Liz de Somer, CEO of Medicines Australia and Sharon Winton, CEO of Lymphoma Australia to explore patient engagement from the perspectives of industry and patient associations. Liz and Sharon are also speaking about this topic at the MAPA/MAPS Medical Affairs Summit in Sydney, AU, Nov 8-10, 2023.
-
This podcast reviews new ways of identifying and quantifying opportunities for field medical impact with disease-state analytics. Industry experts from Pfizer and Veeva discuss how longitudinal patient-level data can pave the way for a more patient-centric way of informing and shaping Medical Affairs strategy and operations.
-
MAPS speaks with Amit Lalwani, omnichannel lead and executive committee member of Medical Affairs Professionals of Australasia and member of the core planning team for the MAPA/MAPS Medical Affairs Summit in Sydney, Australia, November 8-10.
-
When we look at AI, and in particular natural language processing, we think about how we can use these new tools in the medical information space. How do we see the new generative AI models changing what medical information has been doing, especially in the context of chatbots and information dissemination? In this podcast, we interview Matt Lewis, Chief AI Officer at Inizio Medical, a well-regarded expert in data analytics and augmented intelligence.
-
At MAPS Global 2023, “omnichannel in Medical Affairs” was a hot topic across numerous sessions. As part of the Field Medical track, Rosie Humphreys, Senior Director at OPEN Health, Donnie Wooten Jr., Global Head of Strategic Medical Content & Omnichannel at Organon and Kelly Lo, Field Medical Excellence, Global and Japan and Asia Pacific at Amgen conducted an interactive workshop, entitled “Optimize your Field Medical Team for the Omnichannel World”. Over 180 attendees, across two sessions, learned how an omnichannel approach is integral to maximizing Field Medical engagement with HCPs. This podcast will discuss the outcomes and insights of that workshop and how Field Medical can build skills and garner support to effectively implement omnichannel strategies.
-
Generative AI technologies are allowing Medical Affairs teams to find insights in more and more diverse data in less time and with more robust results. Here MAPS speaks with experts from Virtual Science AI including CEO, Tom Hughes, Chief Customer Officer, Geraldine Reilly, and Chief Technology Officer, Hans Chen about how this word, "Generative," has elevated the promise of AI — and how innovative Medical Affairs teams are leveraging these technologies to provide value for their organizations while driving patient benefit.
-
This podcast shares results from the latest Wiley HCP survey, which studies the content habits and preferences of over 900+ HCPs, as well as what they mean for improving engagement with healthcare audiences. Listeners will learn practical tips from the experts on the tactics that are driving impact with today's clinicians.
-
Partially recorded at the MAPS America's Annual meeting in Nashville, members of the MAPS Digital FAWG interviewed representatives from seven organizations in the MAPS Partner Circle.
In this podcast, the FINAL part of this 3-part series, our experts in the Digital FAWG tackle the question of: “How does a Medical Affairs organization measure the success, or value, of omnichannel activities?"
-
Partially recorded at the MAPS America's Annual meeting in Nashville, members of the MAPS Digital FAWG interviewed representatives from seven organizations in the MAPS Partner Circle.
In this podcast, part 2 of a 3-part series, our experts in the Digital FAWG tackle the question of: “How does a Medical Affairs organization plan for integrating omnichannel activities?"
-
Partially recorded at the MAPS America's Annual meeting in Nashville, members of the MAPS Digital FAWG interviewed representatives from seven organizations in the MAPS Partner Circle.
In this podcast, part 1 of a 3-part series, our experts in the Digital FAWG tackle the question of: “How do you define omnichannel,” with the hopes of helping listeners improve their understanding of omnichannel, the many definitions of omnichannel, and why it is difficult to implement in Medical Affairs.
-
Welcome to Part 2 of the MAPS Field Medical Focus Area Working Group's two-part podcast series entitled "Communicating the Value of Field Medical". In this second episode, experts from the FAWG will discuss Field Medical with the following goals in mind:
The participant will be able to learn tips on how to explain the Field Medical value proposition to external stakeholdersLearn how to adapt the proposition when you have just a short time in which to explain itLearn how to adapt the proposition to connect to medical customers more quickly - Mostrar mais